• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473

Introduction to 3'-(Methylthio)biphenyl-3-carboxylic acid (CAS No. 885965-43-5) and Its Emerging Applications in Chemical Biology

3'-(Methylthio)biphenyl-3-carboxylic acid, identified by the chemical identifier CAS No. 885965-43-5, is a specialized organic compound that has garnered significant attention in the field of chemical biology due to its unique structural properties and potential biological activities. This biphenyl derivative, characterized by a methylthio (-SCH?) substituent at the 3' position and a carboxylic acid (-COOH) group at the 3 position, presents an intriguing scaffold for further chemical modifications and biological investigations.

The molecular structure of 3'-(Methylthio)biphenyl-3-carboxylic acid consists of two aromatic benzene rings connected at the para positions, with the 3' position of one ring substituted with a methylthio group and the 3 position of the other ring functionalized with a carboxylic acid moiety. This particular arrangement not only imparts distinct electronic and steric properties but also opens up possibilities for diverse interactions with biological targets. The presence of both sulfur and oxygen heteroatoms in the molecule enhances its potential as a ligand or pharmacophore in drug discovery efforts.

In recent years, the interest in biphenyl derivatives has surged due to their versatile applications in medicinal chemistry. The methylthio group, in particular, has been recognized for its ability to modulate receptor binding affinities and metabolic stability, making it a valuable component in the design of bioactive molecules. Furthermore, the carboxylic acid functionality provides a site for further derivatization, enabling the synthesis of esters, amides, or salts that may enhance solubility or bioavailability.

Current research in the field of chemical biology has highlighted the potential of 3'-(Methylthio)biphenyl-3-carboxylic acid as a precursor for developing novel therapeutic agents. Studies have demonstrated its utility in modulating enzyme activity and receptor interactions, particularly in pathways relevant to inflammation, neurodegeneration, and cancer. The compound's ability to engage with biological targets such as kinases, transcription factors, and ion channels makes it a promising candidate for further exploration.

One notable application of 3'-(Methylthio)biphenyl-3-carboxylic acid is in the development of small-molecule inhibitors targeting aberrant signaling pathways in diseases like Alzheimer's and Parkinson's. The biphenyl core is known to exhibit favorable pharmacokinetic properties, while the methylthio and carboxylic acid groups provide specific interactions with disease-relevant proteins. Preliminary studies have shown that derivatives of this compound can inhibit aggregation of amyloid-beta peptides, a hallmark pathological feature of Alzheimer's disease.

Additionally, 3'-(Methylthio)biphenyl-3-carboxylic acid has been explored as a scaffold for anticancer agents. The sulfur-containing moiety is particularly interesting because it can engage with thioredoxin reductase (TrxR), an enzyme overexpressed in many cancers. Inhibiting TrxR has been shown to induce oxidative stress and apoptosis in tumor cells, making this compound a potential lead for further development into anticancer therapeutics.

The synthesis of 3'-(Methylthio)biphenyl-3-carboxylic acid involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include Suzuki-Miyaura cross-coupling reactions for constructing the biphenyl core followed by thiolation and carboxylation steps to introduce the desired functional groups. Advances in synthetic methodologies have enabled more efficient and scalable production processes, facilitating its use in both academic research and industrial applications.

The pharmacological profile of 3'-(Methylthio)biphenyl-3-carboxylic acid is further enhanced by its ability to be modified into various derivatives. For instance, introduction of fluorine atoms at strategic positions can improve metabolic stability and binding affinity. Similarly, conjugation with biomolecules such as peptides or antibodies can expand its therapeutic applications into targeted drug delivery systems.

In conclusion, 3'-(Methylthio)biphenyl-3-carboxylic acid (CAS No. 885965-43-5) represents a compelling chemical entity with significant potential in pharmaceutical research and development. Its unique structural features make it an attractive scaffold for designing molecules with tailored biological activities. As ongoing studies continue to uncover new applications and optimize synthetic routes, this compound is poised to play an important role in advancing therapeutic strategies across multiple disease areas.

• 825-99-0(3-(methylsulfanyl)benzoic acid)
• 728918-92-1(4'-Methylsulfanyl-biphenyl-3-carboxylic Acid)
• 1261964-62-8(3-Methyl-4-(4-methylthiophenyl)benzoic acid)
• 562836-64-0(4-(Methylthio)benzoic acid)
• 1261934-88-6(3-methyl-4-(4-methyl-2-thienyl)benzoic Acid)
• 1261993-47-8(2-(4-methyl-2-thienyl)benzoic Acid)
• 13205-48-6(4-(methylsulfanyl)benzoic acid)
• 728918-90-9([1,1'-Biphenyl]-4-carboxylicacid, 4'-(methylthio)-)
• 5537-72-4(3-(phenylsulfanyl)benzoic acid)
• 252760-02-4(2-(4-Methylthiophenyl)benzoic acid)